ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,647Medicare Part D Prescriptions Filled, Including Refills

Rank: 24 out of 2094

$1.57M Total Retail Price of All Prescriptions

Rank: 22 out of 2094

681 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 681 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 681 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 14,931 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 911 727 1 1
OMEPRAZOLE 816 566 2 4
AMLODIPINE BESYLATE 555 438 3 2
GLIMEPIRIDE 541 412 4 31
ATORVASTATIN CALCIUM 467 346 5 5
DIOVAN 435 329 6 13
METFORMIN HCL 417 300 7 8
CRESTOR 360 270 8 15
ENALAPRIL MALEATE 350 258 9 25
DIOVAN HCT 329 267 10 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 327 255 11 55
METOPROLOL SUCCINATE 325 282 12 9
NAMENDA 301 275 13 32
LEVOTHYROXINE SODIUM 291 266 14 3
ADVAIR DISKUS 249 186 15 36
ZOLPIDEM TARTRATE 243 205 16 14
CLOPIDOGREL 242 209 17 22
NEXIUM 238 173 18 16
DONEPEZIL HCL 237 210 19 20
FUROSEMIDE 228 190 20 6
METOPROLOL TARTRATE 225 160 21 10
TAMSULOSIN HCL 224 185 22 29
SERTRALINE HCL 219 172 23 26
TRAMADOL HCL 213 170 24 33
LISINOPRIL 209 116 25 7
CARVEDILOL 202 151 26 19
ATENOLOL 200 129 27 21
ATELVIA 198 175 28 135
PLAVIX 188 167 29 38
JANUMET 187 136 30 86
SPIRIVA 182 114 31 60
HYDROCODONE-ACETAMINOPHEN 174 76 S3 32 42
NABUMETONE 165 142 33 203
HYDROCHLOROTHIAZIDE 161 100 34 12
SINGULAIR 161 120 34 64
CYMBALTA 155 111 36 61
LYRICA 153 104 37 85
PRAVASTATIN SODIUM 145 117 38 18
LOVAZA 145 90 38 53
GABAPENTIN 144 91 40 23
PROAIR HFA 140 83 41 45
LOSARTAN-HYDROCHLOROTHIAZIDE 136 110 42 52
ALENDRONATE SODIUM 135 125 43 30
JANUVIA 133 106 44 35
TRICOR 129 101 45 99
METFORMIN HCL ER 129 104 45 67
FAMOTIDINE 127 111 47 34
BYSTOLIC 123 107 48 83
WARFARIN SODIUM 122 116 49 11
ZETIA 117 59 50 79
SYMBICORT 117 84 50 149
EXELON 115 108 52 111
LANTUS SOLOSTAR 115 89 52 76
FLUTICASONE PROPIONATE 111 81 54 41
LIPITOR 111 95 54 39
CELEBREX 105 87 56 74
AMLODIPINE BESYLATE-BENAZEPRIL 105 86 56 58
ENALAPRIL-HYDROCHLOROTHIAZIDE 101 81 58 213
HYDRALAZINE HCL 98 69 59 89
MECLIZINE HCL 97 82 60 103
FENOFIBRATE 97 64 60 104
POTASSIUM CHLORIDE 88 80 62 24
LANTUS 84 60 63 66
QUETIAPINE FUMARATE 79 59 64 71
GLYBURIDE-METFORMIN HCL 79 70 R 64 94
IBANDRONATE SODIUM 75 75 66 140
SURE COMFORT ALCOHOL 75 49 66 407
ACTOS 74 55 68 112
LOSARTAN POTASSIUM 72 62 69 17
CLOTRIMAZOLE-BETAMETHASONE 70 48 70 91
OXYCODONE-ACETAMINOPHEN 69 41 S2 71 40
EASY TOUCH 69 62 71 461
INSULIN SYRINGE 68 50 73 143
NAPROXEN 66 29 74 84
LANSOPRAZOLE 65 63 75 144
AZITHROMYCIN 64 49 76 27
DIGOXIN 62 59 77 51
MONTELUKAST SODIUM 62 35 77 128
MIRTAZAPINE 61 44 79 43
PANTOPRAZOLE SODIUM 60 42 80 37
MOMETASONE FUROATE 57 36 81 229
CILOSTAZOL 57 46 81 204
EXFORGE 55 40 83 105
MELOXICAM 54 53 84 49
IBUPROFEN 54 25 84 73
VALSARTAN-HYDROCHLOROTHIAZIDE 54 42 84 225
NIFEDIPINE ER 53 40 87 96
VENTOLIN HFA 53 39 87 132
BENAZEPRIL-HYDROCHLOROTHIAZIDE 52 30 89 339
CYCLOBENZAPRINE HCL 52 21 R 89 115
AGGRENOX 51 51 91 260
HUMULIN 70-30 51 23 91 279
RAMIPRIL 50 38 93 48
FEXOFENADINE HCL 50 34 93 191
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.